About 46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency is a rare disease catalogued by Orphanet (ORPHA:752). It is associated with the HSD17B3 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to 46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency trials.
Search ClinicalTrials.gov for "46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency" or filter by Orphanet code ORPHA:752 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting 46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for 46,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency. Updated daily.